Skip to main content
Download PDF
  • Study protocol
  • Open access
  • Published:

Using hypnotic suggestion in the rehabilitation of working memory capacity after acquired brain injury: study protocol for a randomized controlled trial

Trials volume 25, Article number: 11 (2024) Cite this article

Abstract

Objectives

Establishment of effective evidence-based interventions in rehabilitation of working memory (WM) deficits after acquired brain injury (ABI) is sorely needed. Despite robust evidence for the efficiency of clinical hypnosis in a wide range of clinical conditions, and improved understanding of mechanisms underlying its effects, the potential of clinical hypnosis in cognitive rehabilitation is underexplored. A recent study has shown large effects of hypnotic suggestion on WM capacity following ABI. This randomized controlled trial aims to evaluate and explore the replicability of these findings and examine the generalization of treatment effects. The study will also explore possible mechanisms of change.

Methods

Ninety patients will be recruited from the Sunnaas Rehabilitation Hospital. Inclusion criteria are nonprogressive ABI, minimum 12-month post-injury, ongoing WM deficits, and age between 18 and 67 years. Patients will be randomized to either (a) an intervention group receiving four weekly 1-h sessions with induction and hypnosis, (b) an active control group receiving four weekly 1-h sessions of induction and mindfulness, or (c) a passive control group without intervention. The targeted procedure consists of suggestions about enhancing WM functions, for example through the instantiation of preinjury WM capacity in the present using age regression or through visualizations of brain plasticity. The non-targeted suggestions contain no explicit mention of ABI- or WM-related abilities. Each participant will be assessed at baseline, immediately after intervention, and 6 months after baseline. The primary outcome is the WM index from WAIS-IV and self- and informant-reported WM subscale from BRIEF-A, a questionnaire exploring executive functioning in everyday life. Secondary outcomes include a cognitive composite score derived from tests measuring processing speed, executive functions, learning capacity and memory, and self-reported measures of emotional distress, quality of life, and community integration. Exploratory measures include self-rated ABI and WM-related self-efficacy.

Discussion

Rehabilitation of impaired WM after ABI has hitherto yielded limited transfer effects beyond the training material, i.e., improvement effects on everyday WM capacity, and clinical trials of new interventions are thus warranted. Long-standing empirical evidence demonstrates that hypnosis is an effective therapeutic technique in a wide range of conditions, and recent exploratory research has suggested a high efficacy of hypnosis in improving WM capacity in patients with ABI. However, these extraordinary findings need replication in studies applying scientifically rigorous designs. If successful, our ambition is to provide recommendations and materials to implement hypnotic suggestion as an adjunct treatment following ABI. Study findings may inform future studies exploring the use of clinical hypnosis in other areas of rehabilitation, such as mild TBI, and in other neurological conditions where WM deficit is prominent.

Trial registration

ClinicalTrials.gov NCT05287542. Registered on March 2022

Protocol version

Protocol version 2.0, December 2023.

Peer Review reports

Introduction

Background

Working memory (WM) is regarded as the “sketchpad of conscious thought” [1], a cognitive capacity that holds and manipulates a limited amount of information for a short time in order to produce a response [2]. Multiple brain regions are involved in WM, and WM impairment is one of the most prevalent symptoms after acquired brain injury (ABI) [3], regardless of lesion etiology, localization, and severity [4]. WM is a central cognitive ability upon which rehabilitation for other functions depends and is a predictor for rehabilitation outcome, activity of daily living (ADL), physical rehabilitation, need for community services after discharge from hospital, community participation, and occupational status [5,6,7,8,9,10]. Rehabilitation efforts to improve high-level cognitive functioning following ABI have yielded limited clinically relevant effects so far [11,12,13]. Despite repeated administrations, reviews of biological interventions such as pharmaceuticals [14], noninvasive brain stimulation [15], physical exercise [16], and nutrition [17] show effect sizes in the zero to moderate range. Mindfulness can potentially reduce ABI-related fatigue. However, no significant effect on WM is found [18]. Treatment of WM through computerized training programs is widespread, regardless of systematic reviews reporting small to no clinically WM-relevant changes [19]. A comprehensive review of the brain-training literature reported no evidence for improvements on “far-transfer” cognitive abilities [19]. In other words, the improvements failed to generalize to other capacity-dependent activities [20]. Previous WM rehabilitation efforts have typically focused on “bottom-up” training programs that aim to restore function through repeated drills and graded exercise [12], where transfer of effects to untrained functional domains has not been documented.

In contrast to the train and drill bottom-up approach, the use of clinical hypnoses represents a “top-down” approach and has been suggested by Lindeløv and colleagues [4], to improve WM performance and to potentially enable generalization to other contexts.

The hypnotic state is a condition of openness to suggestions so that they may be used to elicit changes in a diverse array of psychological and bodily functions [21]. Reviews of hypnotic treatment in psychology [22] and medicine [23] are impressive, with demonstrated efficacy for anxiety [24], depression [25, 26], chronic pain [27], and headache [28] as an adjunct or alternative to anesthesia during surgery [29], in neurorehabilitation for motor disorders [30, 31], pain and vertigo [32], and aphasia [33]. Recent publications have made advancements in identifying the neural correlates underlying the hypnotic state [34]. Recently, hypnotic suggestions were found to enhance updating in WM in healthy adults, which was associated with changes in event-related potentials (ERP) in WM-related regions of the brain [35], indicating that hypnotic suggestions can be potent in altering cognitive functions. A few hypnosis studies have been conducted aiming at enhancing cognitive and psychological functions after ABI [36,37,38]. However, previous studies suffer from one or more major methodological weaknesses, such as a lack of control groups, lack of detailed descriptions of participants, randomization, blinding of testers, statistical procedures, and suggestions used during hypnosis.

The only randomized controlled trial (RCT) to date to include hypnosis in WM rehabilitation was performed by Lindeløv and colleagues [4]. This RCT included 68 participants with ABI across 3 treatment arms: an intervention group, an active control group, and a passive control group. The intervention included techniques such as age regression and visualizations of brain plasticity with suggestions about enhancing WM functions through the instantiation of preinjury WM ability in the present. The non-targeted suggestions contained no explicit mention of ABI or WM-related abilities but was otherwise matched in length and procedure, thus serving as an active control. Contrary to previous research, this study reported large effect sizes after only four 1-h sessions in favor of the intervention group compared to both active controls (Bayes factors of 342 and 37.5 on the two aggregate outcome measures) and the passive control group (Bayes factor = 1.7 × 1013). The long-term effect remained at approximately 6-week follow-up (Bayes factors = 7.1 and 1.3 in favor of no change). The outcome measures were neuropsychological tests, i.e., the WM index from WAIS-IV and Trail Making Test A and B. The authors suggest that hypnosis can improve WM following ABI, and that the speed and magnitude of the improvements indicate that there may be a potential for releasing residual cognitive capacity after ABI rather than “building” it anew. However, this study lacked medical data such as brain injury characteristics; it included only a few outcome measures (i.e., neuropsychological tests) and, most importantly, no measures of everyday WM capacity. Furthermore, Lindeløv and colleagues did not explore the potential underlying mechanisms associated with improved WM among the participants.

Self-efficacy theory asserts that an individual’s beliefs in personal competency predict actual performance [24], and ABI survivors often display negative self-expectancies and show lower WM self-efficacy than healthy controls [25]. Self-efficacy influences coping style and quality of life, satisfaction with functioning [26], social participation [27], functional independence [28], and community integration [29] after ABI. Thus, changed expectations about the possibility of dealing with the consequences of brain injury, i.e., improved self-efficacy, are a potential candidate in mediating generalization effects in cognitive rehabilitation [26]. Hypnosis seems to be particularly well positioned to enhance self-efficacy [30] and change expectations of psychological and behavioral outcomes in order to build confidence in one’s ability to cope with or solve problems [31, 32, 39, 40]. A person’s brain injury expectations may influence their cognitive performances through mechanisms similar to the nocebo effect [41]. Nocebo is a self-fulfilling prophecy where adverse effects are produced by expectations [42, 43]. The Cognitive Activation Theory of Stress (CATS) [44] suggests that expectancies regulate bodily stress responses [45]. This is relevant to the current study given the established negative influence of stress-related cortisol on WM capacity [46]. Specifically, expectations about coping (i.e., self-efficacy) may reduce the stress response, while expectations of helplessness or hopelessness may sustain it [44, 47]. This study will test the hypothesis that hypnosis in WM rehabilitation exerts its effect partly through changes in WM self-efficacy.

Objectives and hypothesis

The main objective of this study is to explore the effect of hypnotic suggestion on WM capacity in adults with ABI. The following three research questions will be explored:

  1. 1.

    Are the strong effect of hypnotic suggestion on WM performance in ABI patients found by Lindeløv et al. (2017) replicable?

Our hypothesis is that the direction and the magnitude of the effects on WM found by Lindeløv and colleagues after four treatment sessions will be replicated. Given the large changes seen in Lindeløv et al.’s study, even weaker results are of clinical interest.

  1. 2.

    Does hypnotic suggestions improve everyday WM, everyday functioning and participation, emotional status, and quality of life in ABI patients?

The intervention is hypothesized to improve WM performance through “top-down” processes, which will allow improved WM capacity to be applied across diverse tasks and contexts. Thus, we expect to see treatment-related change in the domains of daily life, emotional status, and quality of life.

  1. 3.

    Does increased self-efficacy predict the effect of hypnosis on WM?

We hypothesize that changes in self-efficacy predict WM improvements following hypnosis.

Methods

Trial design

The study is organized as a randomized controlled superiority trial with parallel group design and three arms including (1) an intervention group, (2) an active control group, and (3) a passive control group. Participants will be randomly allocated in a 1:1:1 ratio to either of the three groups. The intervention group will receive four weekly 1-h sessions with hypnosis treatment (induction + hypnotic suggestion), while the active control group will receive four weekly 1-h sessions of non-targeted hypnotic suggestions (induction + mindfulness-based instructions) to factor out nonspecific treatment effects. The passive control group will be assessed at the same time points as the other two groups to isolate retest effects. Each participant will be assessed three times: (1) at baseline (T1), (2) immediately after the intervention which is 5 weeks post baseline (T2), and (3) 25 weeks after baseline (T3, follow-up). The study will follow the CONSORT statement facilitating complete and transparent reporting and aiding critical appraisal and interpretation (http://www.consort-statement.org/). This study expands the design of Lindeløv et al.’s study through a larger number of participants, the inclusion of far-transfer outcome measures, and the exploration of potential underlying mechanisms of treatment effects. Because this study is performed in collaboration with the principal investigator of the original study [4], we rely on learnings from that study rather than conducting a small-scale pre-study pilot and/or feasibility trial. The intervention will be based on the hypnosis scripts by Lindeløv et al. translated from Danish to Norwegian [4].

Study setting and participants

Eligible participants are recruited at the department of cognitive rehabilitation at Sunnaas Rehabilitation Hospital (Bjørnemyrveien 11, 1453 Bjørnemyr, Norway). The department discharge approximately 370 patients a year making it realistic to reach the target sample size. Assessments and interventions will be conducted at the outpatient clinic at the Sunnaas Rehabilitation Hospital. The therapist will collect signed written informed consent forms before baseline assessments.

Eligibility criteria (10)

Inclusion and exclusion criteria

Inclusion criteria are a documented nonprogressive ABI, minimum 12-month post-injury, ongoing WM deficits (by self-report and/or neuropsychological assessment), and age between 18 and 67 years. Exclusion criteria are severe mental illness (e.g., diagnosed major depressive disorder, schizophrenia, or bipolar disorder), progressive neurologic disease, and/or ongoing ICD-10 diagnosis of substance use disorder or lack of Norwegian language skills. Participants will be discouraged from participating in intensive in-patient cognitive rehabilitation while included in the trial but will not ask them to refrain from ordinary long-term community-based treatment such as physiotherapy and/or occupational therapy. Service provision during the trial will be documented.

Included measures

Three sources of data will be collected: (1) demographic and medical data, (2) performance-based neuropsychological measures, and (3) subjective ratings of WM, emotional distress (anxiety and depression), quality of life, activity, and community integration (Fig. 1).

Fig. 1
figure 1

Standard Protocol Items: Recommended for Intervention Trials (SPIRIT)

Full size image

Patient characteristics

Sociodemographic variables will include age, gender, marital status, children, living conditions, years of education, profession, and study or employment status. Medical variables include preexisting comorbidity, substance use, concurrent somatic and psychiatric diseases and injury characteristics of interest time since injury, etiology, and results of radiological examinations for lesion characterization.

Interventions

The treatment protocol is identical to the study that is being replicated. During the first phase of the study, the treatment group and the active control group will receive identical procedures, including welcoming, hypnotic inductions, hypnotic re-alerting, and farewell. The groups differ in between the hypnotic induction and hypnotic re-alerting. The targeted procedure consists of suggestions about enhancing WM functions through the instantiation of preinjury WM ability in the present using age regression and visualizations of brain plasticity. The non-targeted suggestions contain no explicit mention of brain injury or WM-related abilities and thus serve as an active control, i.e., to isolate the ‘targetedness’ of suggestion as the independent variable by factoring out other influences from placebo, retest effects, etc. These non-targeted suggestions are borrowed from mindfulness meditation practices, involving body and thought awareness as they have demonstrated no or small effects on cognitive abilities in participants with ABI [48, 49]. All sessions will last for about 1 h, and the patients are invited to either sit in a comfortable chair or lay down on a bench during the procedures. We have access to the full treatment manual used by Lindeløv et al. in Danish. The manual has been translated into Norwegian. Throughout the spring of 2021, we tested the manual with the active treatment condition with two user representatives at Sunnaas Rehabilitation Hospital. This has given us the opportunity for closer collaboration with users regarding feasibility and adherence to intervention protocol.

To secure compliance to the protocol, regular supervision is provided to the therapist conducting the intervention. There are few side effects of hypnosis, and most people report well-being after hypnotic intervention. Participants are informed about the harmless nature of hypnosis, but also that if they wish to end the session for any reason, treatment will be immediately aborted. The therapist registers any occurrence of uncomfortableness or adverse effects of the treatment. Participants will further be informed that this is an experimental study with unknown effects. Participation is not time-consuming and will not be at the expense of other treatment.

Outcomes

The main objective outcome measure is the WM index from WAIS-IV, and the main subjective outcome is the self- and informant-reported WM subscale from the Behavior Rating Inventory of Executive Function–Adult version (BRIEF-A) [50]. Secondary objective outcome measures include neuropsychological tests measuring (1) processing speed (Trail Making Test Part A (TMTA)), Color Word Interference Test (CWIT) parts 1 and 2 from Delis-Kaplan Executive Function System (D-KEFS), and Digit Symbol Test from Wechsler Adult Intelligence Scale 4th Edition (WAIS-IV) [51], (2) executive functions (CWIT parts 3 and 4 from D-KEFS [52] and Trail Making Part B (TMT B)), and (3) learning capacity and memory (California Verbal Learning Test (CVLT-II)). Secondary subjective outcomes include the following: (1) emotional distress (The Hopkins Symptom Checklist (HSCL)) [53], (2) quality of life (QOLIBRI) [54], (3) community integration (Patient Competency Rating Scale (PCRS) [55], and (4) everyday participation (The Participation Assessment with Recombined Tools-Objective (Part-O)). Changes in self-efficacy will be measures with the Traumatic Brain Injury Self-Efficacy Questionnaire (TBI-SE) [56] and the Memory Self-Efficacy Questionnaire (MSEQ) [57]. All measures will be applied at all three time-points (Table 1).

Table 1 Overview over measures included at baseline and outcome assessments
Full size table

Participant timeline

A study flowchart is provided in Fig. 2.

Fig. 2
figure 2

Trial design

Full size image

Sample size and power calculations

Although Lindeløv et al. [4] found large treatment effects, their novel and unreplicated nature causes us to design a study that will also be informative with medium effect sizes. We set a sample size so that we can detect clinically meaningful changes of 0.5 SD on the primary outcome measures, i.e., the WAIS-IV Working Memory Index and BRIEF-A Working Memory Scale. Computed in G*Power, the group × time within-between interaction effect would require 22 completers in each group for a medium-sized effect (ηp2 = 0.07), 1% significance level (due to corrections for multiple testing), and a power of 90%. Allowing for a 20–25% drop-out rate brings the required sample to 30 participants per group, i.e., a total of n = 90. The success criterion in this study is thus defined as medium effect sizes (ηp2 = 0.07).

Randomization and blinding

Eligible patients will be identified by the study PI (author L. S. E.) from the department of cognitive rehabilitation (KReSS) at Sunnaas Rehabilitation Hospital. After baseline assessment, participants will be randomly allocated to either of the three groups. The randomization sequence will be generated electronically in STATA by an independent statistician.

The allocation sequence will be stored in a database that can only be accessed by the study’s principal investigator. It will not be possible to blind neither the participants nor the PhD candidate who will conduct the hypnotic suggestions. Outcome assessments will, however, be blinded in that a person external to the study will perform these without knowledge of group allocation. Our research group has extensive experience in managing blinded clinical trials, and we are confident that this can be conducted in a truly blinded way without contamination. Data analysis will also be blinded in that fake ID numbers will be assigned to participants in the final database, ensuring that the statistical analysis is performed without knowledge of true group content until after the analyses are finalized.

Dropout and data retention

Participants that want to exit the study can do so at any given time by informing the study PI or the therapist providing the treatment. Their names and contact information are provided in the consent form. In case of dropout, the participant is asked if they are willing to report why they want to exit the study. If information regarding reason for exit of the study is provided, the information is registered on a dedicated drop-out sheet. Unless the participant requires all their data deleted, data is still included in the intention-to-treat (ITT) analyses.

Statistical methods

Intention-to-treat (ITT) analysis will be applied, using data from all randomized participants, regardless of whether they complete the intervention. Descriptive statistics will be reported for sample description and outcome measures. The effect of the intervention will be assessed by linear mixed-effect models fitting the primary and secondary continuous outcome variables to account for repeated measurements by patients. Time (T1, T2, and T3) and time-by-treatment interaction will be used as fixed effects in these models. The main effect of group will be included to control for potential baseline differences. Based on the linear mixed effect models, we will estimate mean values with 95% confidence intervals (CI) for the three time points (T1, T2, and T3) for each treatment group. We will also estimate the mean between-group changes from T1 to T3. These models account for missing data on individual time points, thus obviating the need to impute missing values. We will preregister the analytic strategy. The role of self-efficacy on the effect of hypnosis will be explored with linear regression models. No interim analyses will be performed.

Ethical issues

The intervention will be carried out in accordance with guidelines from the Norwegian Society of Clinical Evidence-Based Hypnosis (NFKEH) by a clinical psychologist educated in hypnotherapy. Written, informed consent to participate will be obtained from all participants. The study will be conducted in accordance with the Declaration of Helsinki and the Vancouver recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. The study has been approved by the Regional Committee for Medical and Health Research Ethics (approval number 216495) and the Norwegian Center for Research Data (NSD) (approval number 291031). The research is registered and made public at the Clinical Trials and Open Science Framework.

Dissemination plans

The study results will be presented at Norwegian and international conferences in neurology, brain injury, and rehabilitation and in various arenas in which the Norwegian Union of Stroke (NFS) is active. The study results will be disseminated in Norwegian academic environments, and popular scientific presentations will be given. The results will also be communicated to the public through commercial channels like newspaper articles and social media. A dissemination strategy will be established in collaboration with the user panel who will actively participate in disseminating the findings and their relevance for patients through their channels. Given the close collaboration between Sunnaas Rehabilitation Hospital and other rehabilitation centers in Norway, we are well-positioned to communicate findings to other hospitals and stakeholders. Moreover, the Norwegian Society of Clinical Evidence-Based Hypnosis (NFKEH) provides education in hypnosis to health personnel subjected by the Norwegian Health Personnel Act. Since the head of NFKEH participates in this study, clinical hypnosis education of neurorehabilitation professionals will be provided.

Discussion

The potential impact of applying hypnosis in cognitive rehabilitation is substantial. Deficits in WM are one of the most common challenges after ABI [3] and play a critical role in post-injury outcome [29]. Still, state-of-the-art approaches within WM rehabilitation have not been able to produce clinically relevant effects on real-life functioning for the affected patients [19]. In addition, today’s ABI rehabilitation is often time-consuming and requires hospitalization. As described by, e.g., Cicerone and colleagues [12], there is a need for more effective cognitive rehabilitation methods. Long-standing empirical evidence demonstrates that hypnosis is an effective therapeutic technique for a wide range of conditions [23], including in altering cognitive functions and improving WM in healthy adults. These findings are supported by changes seen in functional MRI [58] and event-related potentials [35]. Recent explorative research has suggested a promising efficacy of hypnosis in improving WM capacity in patients with ABI [4]. However, these findings are in need of replication in studies applying scientifically rigorous designs, and there is a need to understand potential underlying mechanisms of change.

Building on the strong results in the Danish single trial, we will aim at replication and expansion of the study in a Norwegian context. The initial study will be expanded in terms of the number of participants, injury characteristics will be included, and outcome measures of relevance to real-life functioning and possible underlying mechanisms of change will be explored. Self-efficacy is generalizable by nature (self-efficacy gained from mastery experiences in one situation generalizes to others); thus, WM rehabilitation effects are expected to generalize and transfer to other domains in daily life.

If previous findings are replicated, and transfer effects documented, patients may have improved WM capacity, including everyday WM, improved activities of daily living, self-efficacy, psychological well-being, and quality of life. These factors are critical to independence and may in turn affect the need for community support, community integration, and return to work. The intervention is manual based and short (four sessions) and is conducted in an outpatient clinic. Hypnotic interventions are typically brief, cost-effective, suitable for both in- and outpatients, for adolescents and adults, and can be learned easily; suggestions can be administered either by another person (hetero-hypnosis) or self-administered (self-hypnosis), adding portability to the mix of benefits. As the study that is being replicated is the only one to test hypnosis in rehabilitation of WM, a lack of replication, i.e., null findings, would also be highly informative to the field. Regardless of outcome, this study can provide valuable insights to other research groups and inform future studies. Study findings may inform future studies exploring the use of clinical hypnosis in other areas of rehabilitation, such as mild TBI (i.e., post-concussion symptoms), and in other neurological conditions where WM deficit is prominent, such as multiple sclerosis and Parkinson’s disease. A next step could also be to explore potential effects beyond the domain of WM, as studies have shown that self-efficacy is associated with mental health [27], quality of life [26], functional independence [28], and community integration [29]. This study thus has the potential to influence how we understand the clinical significance of psychological factors, like self-efficacy, on functioning after ABI. If successful, our ambition is to provide recommendations and materials to implement hypnotic suggestion as an adjunct treatment following ABI in Norwegian rehabilitation clinics.

Trial status

The study was approved by the Regional Committee for Medical and Health Research Ethics in May 2021 and funded by Foundation Dam in December 2021. Recruitment for the RCT began at Sunnaas Rehabilitation Hospital in October 2022 and will end when we have enrolled the estimated sample size of 90, estimated June/July 2024.

Plans for communicating important protocol modifications

Protocol modifications of importance will be reported to the Data Protection Office at Sunnaas Hospital, and amendments will be made to the trial registry (ClinicalTrials.gov) and Open Science Framework.

Availability of data and materials

Data will be stored electronically on a secure research server at Sunnaas Rehabilitation Hospital. The data will be kept for 5 years after the end of the project for control reasons. All principal investigators will be given access to the cleaned data sets. Access to data is regulated by Norwegian laws regarding data protection and research ethics.

Abbreviations

ABI:

Acquired brain injury

WM:

Working memory

ADL:

Activity of daily living

RCT:

Randomized controlled trial

CATS:

Cognitive activation theory of stress

NFKEH:

The Norwegian Association of Clinical Evidence-based Hypnosis

ITT:

Intention to treat

WAIS-IV:

Wechsler Adult Intelligence Scale–Fourth Edition

TMTA:

Trail Making Test Part A

TMTB:

Trail Making Test Part B

CVLT-II:

California Verbal Learning Test–Second Edition

BRIEF-A:

Behavior Rating Inventory of Executive Function–Adult version

TBI-SE:

The Traumatic Brain Injury Self-Efficacy Questionnaire

MSEQ:

The Memory Self-Efficacy Questionnaire

HSCL:

The Hopkins Symptom Checklist

QOLIBRI:

Quality of life

PCRS:

Patient Competency Rating Scale

Part-O:

The Participation Assessment with Recombined Tools-Objective

References

  1. Miller EK, Lundqvist M, Bastos AM. Working memory 2.0. Neuron. 2018;100(2):463–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Baddeley A. Working memory. Science. 1992;255(5044):556–9.

    Article  CAS  PubMed  Google Scholar 

  3. Constantinidis C, Klingberg T. The neuroscience of working memory capacity and training. Nat Rev Neurosci. 2016;17(7):438.

    Article  CAS  PubMed  Google Scholar 

  4. Lindelov JK, Overgaard R, Overgaard M. Improving working memory performance in brain-injured patients using hypnotic suggestion. Brain. 2017;140(4):1100–6.

    Article  PubMed  Google Scholar 

  5. Cicerone KD. Remediation of “working attention” in mild traumatic brain injury. Brain Inj. 2002;16(3):185–95.

    Article  PubMed  Google Scholar 

  6. Lundqvist A, et al. Computerized training of working memory in a group of patients suffering from acquired brain injury. Brain Inj. 2010;24(10):1173–83.

    Article  PubMed  Google Scholar 

  7. Fitri FI, Fithrie A, Rambe AS. Association between working memory impairment and activities of daily living in post-stroke patients. Med Glas (Zenica). 2020;17(2):433–8.

    Google Scholar 

  8. Oros RI, et al. The impact of cognitive impairment after stroke on activities of daily living. Hum Vet Med. 2016;8(1):41–4.

    Google Scholar 

  9. Shigaki CL, Frey SH, Barrett AM. Rehabilitation of poststroke cognition. Semin Neurol. 2014;34(5):496–503.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Sigurdardottir S, et al. Return to work after severe traumatic brain injury: a national study with a one-year follow-up of neurocognitive and behavioural outcomes. Neuropsychol Rehabil. 2020;30(2):281–97.

    Article  PubMed  Google Scholar 

  11. Melby-Lervåg M, Redick TS, Hulme C. Working memory training does not improve performance on measures of intelligence or other measures of “far transfer”: evidence from a meta-analytic review. Perspect Psychol Sci. 2016;11(4):512–34.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Cicerone KD, et al. Evidence-based cognitive rehabilitation: systematic review of the literature from 2009 through 2014. Arch Phys Med Rehabil. 2019;100(8):1515–33.

    Article  PubMed  Google Scholar 

  13. Simons DJ, et al. Do “brain-training” programs work? Psychol Sci Public Interest. 2016;17(3):103–86.

    Article  PubMed  Google Scholar 

  14. Sharma T, Antonova L. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr Clin North Am. 2003;26(1):25–40.

    Article  PubMed  Google Scholar 

  15. Alashram AR, Padua E, Annino G. Noninvasive brain stimulation for cognitive rehabilitation following traumatic brain injury: a systematic review. Appl Neuropsychol Adult. 2023;30(6):814–29.

    Article  PubMed  Google Scholar 

  16. Johnson L, et al. The effect of physical activity on health outcomes in people with moderate-to-severe traumatic brain injury: a rapid systematic review with meta-analysis. BMC Public Health. 2023;23(1):63.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Dolan E, Gualano B, Rawson ES. Beyond muscle: the effects of creatine supplementation on brain creatine, cognitive processing, and traumatic brain injury. Eur J Sport Sci. 2019;19(1):1–14.

    Article  PubMed  Google Scholar 

  18. Lovette BC, et al. “Hidden gains”? Measuring the impact of mindfulness-based interventions for people with mild traumatic brain injury: a scoping review. Brain Inj. 2022;36(9):1059–70.

    Article  PubMed  Google Scholar 

  19. Niemeijer M, Sværke KW, Christensen HK. The effects of computer based cognitive rehabilitation in stroke patients with working memory impairment: a systematic review. J Stroke Cerebrovasc Dis. 2020;29(12):105265.

    Article  PubMed  Google Scholar 

  20. Barnett SM, Ceci SJ. When and where do we apply what we learn?: A taxonomy for far transfer. Psychol Bull. 2002;128(4):612.

    Article  PubMed  Google Scholar 

  21. Oakley DA, Halligan PW. Hypnotic suggestion: opportunities for cognitive neuroscience. Nat Rev Neurosci. 2013;14(8):565–76.

    Article  CAS  PubMed  Google Scholar 

  22. Valentine KE, et al. The efficacy of hypnosis as a treatment for anxiety: a meta-analysis. Int J Clin Exp Hypn. 2019;67(3):336–63.

    Article  PubMed  Google Scholar 

  23. Kittle J, Spiegel D. Hypnosis: the most effective treatment you have yet to prescribe. Am J Med. 2021;134(3):304–5.

    Article  PubMed  Google Scholar 

  24. Bandura A. Self-efficacy: the excercise of control. New York: W.H. Freeman and Company; 1997.

    Google Scholar 

  25. Kit KA, Mateer CA, Graves RE. The influence of memory beliefs in individuals with traumatic brain injury. Rehabil Psychol. 2007;52(1):25–32.

    Article  Google Scholar 

  26. Cicerone KD, Azulay J. Perceived self-efficacy and life satisfaction after traumatic brain injury. J Head Trauma Rehabil. 2007;22(5):257–66.

    Article  PubMed  Google Scholar 

  27. Brands I, et al. Influence of self-efficacy and coping on quality of life and social participation after acquired brain injury: a 1-year follow-up study. Arch Phys Med Rehabil. 2014;95(12):2327–34.

    Article  PubMed  Google Scholar 

  28. Parker HA, et al. Functional independence after acquired brain injury: Prospective effects of health self-efficacy and cognitive impairment. Rehabil Psychol. 2018;63(4):595–603.

    Article  PubMed  Google Scholar 

  29. Cicerone K, et al. Community integration and satisfaction with functioning after intensive cognitive rehabilitation for traumatic brain injury. Arch Phys Med Rehabil. 2004;85:943–50.

    Article  PubMed  Google Scholar 

  30. Barker J, Jones M, Greenlees I. Using hypnosis to enhance self-efficacy in sport performers. J Clin Sport Psychol. 2013;7:228–47.

    Article  Google Scholar 

  31. Kirsch I. Response expectancy as a determinant of experience and behavior. Am Psychol. 1985;40(11):1189–202.

    Article  Google Scholar 

  32. Perfect MM, Champagne C. Hypnosis and the potential application in the school setting; 2020.

    Book  Google Scholar 

  33. Caban AR. In: Barabasz M, editor. Effects of hypnosis on the academic self-efficacy of first-generation college students. Pullman, Washington: Washington State University; 2004.

    Google Scholar 

  34. Jiang H, et al. Brain activity and functional connectivity associated with hypnosis. Cereb Cortex. 2017;27(8):4083–93.

    PubMed  Google Scholar 

  35. Zahedi A, Stürmer B, Sommer W. Can posthypnotic suggestions boost updating in working memory? Behavioral and ERP evidence. Neuropsychologia. 2020;148:107632.

    Article  PubMed  Google Scholar 

  36. Vanhaudenhuyse A, Laureys S, Faymonville ME. The use of hypnosis in severe brain injury rehabilitation: a case report. Acta Neurol Belg. 2015;115(4):771–2.

    Article  PubMed  Google Scholar 

  37. Fromm E, Sawyer J, Rosenthal V. Hypnotic simulation of organic brain damage. J Abnorm Psychol. 1964;69:482–92.

    CAS  PubMed  Google Scholar 

  38. Wagstaff G, Parkes M, Hanley J. A comparison of posthypnotic amnesia and the simulation of amnesia through brain injury. Int J Psychol Psychol Ther. 2001;1(1):68–78.

    Google Scholar 

  39. Caban AR. Effects of hypnosis on the academic self-efficacy of first-generation college students; 2004.

    Google Scholar 

  40. Barker J, Jones M, Greenlees I. Assessing the immediate and maintained effects of hypnosis on self-efficacy and soccer wall-volley performance. J Sport Exerc Psychol. 2010;32(2):243–52.

    Article  PubMed  Google Scholar 

  41. Polich G, et al. Placebo effects in traumatic brain injury. J Neurotrauma. 2018;35(11):1205–12.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Colloca L, Miller FG. The nocebo effect and its relevance for clinical practice. Psychosom Med. 2011;73(7):598–603.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Colloca L, Barsky AJ. Placebo and nocebo effects. N Engl J Med. 2020;382(6):554–61.

    Article  CAS  PubMed  Google Scholar 

  44. Ursin H, Eriksen HR. The cognitive activation theory of stress. Psychoneuroendocrinology. 2004;29(5):567–92.

    Article  PubMed  Google Scholar 

  45. Reme SE, Eriksen HR, Ursin H. Cognitive activation theory of stress--how are individual experiences mediated into biological systems? Scand J Work Environ Health. 2008;34(6):177.

    Google Scholar 

  46. Garg MK, Mittal M. Structural and functional consequences of hypercortisolism on brain: are the brain and psycho-neuro-cognitive manifestations reversible? Indian J Endocrinol Metab. 2020;24(6):507.

    Article  PubMed  Google Scholar 

  47. Munk A, Reme SE, Jacobsen HB. What does CATS have to do with cancer? The cognitive activation theory of stress (CATS) forms the SURGE model of chronic post-surgical pain in women with breast cancer. Front Psychol. 2021;12:872.

    Article  Google Scholar 

  48. Johansson B, Bjuhr H, Rönnbäck L. Mindfulness-based stress reduction (MBSR) improves long-term mental fatigue after stroke or traumatic brain injury. Brain Inj. 2012;26(13-14):1621–8.

    Article  CAS  PubMed  Google Scholar 

  49. McMillan T, et al. Brief mindfulness training for attentional problems after traumatic brain injury: a randomised control treatment trial. Neuropsychol Rehabil. 2002;12(2):117–25.

    Article  Google Scholar 

  50. Roth R, Isquith P, Gioia G. Behavior Rating Inventory of Executive Function-Adult Version. Lutz, FL: PAR; 2005.

    Google Scholar 

  51. Wechsler D. Wechsler Adult Intelligence Scale. 4th ed. Psychological Corporation; 2008.

    Google Scholar 

  52. Delis, D. C., Kaplan, E., & Kramer, J. H., Delis-Kaplan executive function system (D-KEFS). 2001.

  53. Derogatis LR, et al. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1–15.

    Article  CAS  PubMed  Google Scholar 

  54. von Steinbüchel N, et al. Quality of Life after Brain Injury (QOLIBRI): scale development and metric properties. J Neurotrauma. 2010;27:1167–85.

    Article  Google Scholar 

  55. Prigatano Fordyce, D.J., Zeiner, H.K., Roueche, J.R., Pepping, M., & Wood, B.C., G P, Neuropsychological rehabilitation after brain injury. 1986.

  56. Lorig K, et al. Outcome measures for health education and other health care interventions. Sage; 1996.

    Book  Google Scholar 

  57. West RL, Bagwell DK, Dark-Freudeman A. Memory and goal setting: the response of older and younger adults to positive and objective feedback. Psychol Aging. 2005;20(2):195–201.

    Article  PubMed  Google Scholar 

  58. Jiang H, et al. Brain activity and functional connectivity associated with hypnosis. Cerebral Cortex. 2016;27(8):4083–93.

    PubMed Central  Google Scholar 

  59. Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin J, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleža-Jerić K, Laupacis A, Moher D. SPIRIT 2013 Explanation and Elaboration: Guidance for protocols of clinical trials. BMJ. 2013;346:e7586

Download references

Acknowledgements

We would like to acknowledge financial support received from the Foundation Dam, contributions from the Norwegian Union of Stroke (NFS), and the Norwegian Association of Clinical Evidence-Based Hypnosis (NFKEH). Further gratitude to all participants for their time and effort.

Confidentiality

All collected information will be processed without name and national identification numbers or other direct identifiers information (= coded information). Only the project manager has access to a list linking the code with a name-list.

Funding

The project is funded by Foundation Dam in Norway, project number 2022/FO38702.

Author information

Authors and Affiliations

  1. Sunnaas Rehabilitation Hospital, Nesodden, Norway

    Line Sophie Eide, Per-Ola Rike, Hildegun Snekkevik & Marianne Løvstad

  2. University of Oslo (UiO), Oslo, Norway

    Silje Endresen Reme & Marianne Løvstad

  3. Norwegian Society of Clinical Evidence-Based Hypnosis (NEKEH), Oslo, Norway

    Line Sophie Eide, Stephan Rossner & Gunnar Rosen

  4. Molde Hospital, Molde, Norway

    Stephan Rossner

  5. Aalborg University (AAU), Aalborg, Denmark

    Jonas Kristoffer Lindeløv

Authors
  1. Line Sophie Eide
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Per-Ola Rike
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Silje Endresen Reme
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hildegun Snekkevik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephan Rossner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gunnar Rosen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jonas Kristoffer Lindeløv
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marianne Løvstad
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LSE, POR, and ML have contributed to the conception, design, and funding of the study and are involved in all aspects of the study. ML is the PI of the study. JKL has provided scientific advice based on his similar previous research, and SER has provided scientific guidance. LSE, POR, ML, JKL, and SR contributed to the final study design and choice of methods. SR and GR are senior clinicians with expertise in clinical hypnosis and have given advice regarding hypnosis procedures. SR supervises the treatment during the study. HS is involved in recruitment throughout. All authors have contributed to draft the manuscript and consent to publication. All authors have reviewed and approved the final manuscript.

Corresponding author

Correspondence to Line Sophie Eide.

Ethics declarations

Ethics approval and consent to participate

The study has been approved by the Regional Committee for Medical and Health Research Ethics (approval number 216495) and the Norwegian Center for Research Data (NSD) (approval number 291031).

Consent for publication

Not applicable because no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Spirit checklist [59].

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eide, L.S., Rike, PO., Reme, S.E. et al. Using hypnotic suggestion in the rehabilitation of working memory capacity after acquired brain injury: study protocol for a randomized controlled trial. Trials 25, 11 (2024). https://doi.org/10.1186/s13063-023-07867-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13063-023-07867-z

Keywords

Trials

ISSN: 1745-6215